Pfizer Covid Pill Paxlovid
- All
- News
- Videos
-
WHO "Strongly Recommends" Pfizer's Antiviral Covid pill
The World Health Organization said Friday it "strongly recommended" Pfizer's Covid-19 antiviral pill Paxlovid for patients with milder forms of the disease who were still at a high risk of hospitalisation.
-
China Gives Conditional Nod To Pfizer Covid Pill Amid Isolated Flare-Ups
China on Saturday said it had given "conditional" approval for Pfizer's Covid-19 drug Paxlovid to treat adults with mild to moderate illness and a high risk of developing severe disease.
-
Pfizer Covid Pill Europe's First Approved Oral Treatment Against Covid
The EU's drug watchdog approved Pfizer's coronavirus pill on Thursday, making it the first oral antiviral treatment for the disease to be authorised in Europe.
-
South Korea To Deploy Pfizer COVID-19 Pills As Omicron Wave Looms
South Korea will begin treating coronavirus patients with Pfizer's antiviral pills on Friday, health officials said, as concern mounts over the spread of the highly contagious Omicron variant.
-
Joe Biden Doubles US Purchase Of Pfizer Covid Pills As Cases Surge
President Joe Biden announced Tuesday a doubling of US government purchases of new Pfizer therapeutic pills designed to combat the worst effects of Covid-19.
-
South Korea Authorises Emergency Use Of Pfizer's Antiviral Covid Pill
South Korea authorised for emergency use Pfizer's antiviral pills targeting COVID19 as the first of its kind to be introduced in South Korea, the Ministry of Food and Drug Safety.
-
Pfizer Announces Plan To Sell 10 Million Covid Pills To US For Over $5 Billion
Pfizer said Thursday it will sell 10 million COVID-19 treatment courses for COVID-19 to the US government for $5.3 billion, pending approval from regulators.
-
Game-Changing Made-In-India Anti-Covid Pills Could Be Cleared For Use In Days
Emergency Use Authorisation for the Merck drug Molnupiravir -- an oral antiviral medicine for the treatment of mild-to-moderate COVID-19 -- is likely "within days", Dr Ram Vishwakarma, Chairman of the Covid Strategy Group, CSIR, told NDTV today.
-
WHO "Strongly Recommends" Pfizer's Antiviral Covid pill
The World Health Organization said Friday it "strongly recommended" Pfizer's Covid-19 antiviral pill Paxlovid for patients with milder forms of the disease who were still at a high risk of hospitalisation.
-
China Gives Conditional Nod To Pfizer Covid Pill Amid Isolated Flare-Ups
China on Saturday said it had given "conditional" approval for Pfizer's Covid-19 drug Paxlovid to treat adults with mild to moderate illness and a high risk of developing severe disease.
-
Pfizer Covid Pill Europe's First Approved Oral Treatment Against Covid
The EU's drug watchdog approved Pfizer's coronavirus pill on Thursday, making it the first oral antiviral treatment for the disease to be authorised in Europe.
-
South Korea To Deploy Pfizer COVID-19 Pills As Omicron Wave Looms
South Korea will begin treating coronavirus patients with Pfizer's antiviral pills on Friday, health officials said, as concern mounts over the spread of the highly contagious Omicron variant.
-
Joe Biden Doubles US Purchase Of Pfizer Covid Pills As Cases Surge
President Joe Biden announced Tuesday a doubling of US government purchases of new Pfizer therapeutic pills designed to combat the worst effects of Covid-19.
-
South Korea Authorises Emergency Use Of Pfizer's Antiviral Covid Pill
South Korea authorised for emergency use Pfizer's antiviral pills targeting COVID19 as the first of its kind to be introduced in South Korea, the Ministry of Food and Drug Safety.
-
Pfizer Announces Plan To Sell 10 Million Covid Pills To US For Over $5 Billion
Pfizer said Thursday it will sell 10 million COVID-19 treatment courses for COVID-19 to the US government for $5.3 billion, pending approval from regulators.
-
Game-Changing Made-In-India Anti-Covid Pills Could Be Cleared For Use In Days
Emergency Use Authorisation for the Merck drug Molnupiravir -- an oral antiviral medicine for the treatment of mild-to-moderate COVID-19 -- is likely "within days", Dr Ram Vishwakarma, Chairman of the Covid Strategy Group, CSIR, told NDTV today.
